Bio-Techne Corp. (TECH)

200.25
NASDAQ : Health Technology
Prev Close 201.50
Day Low/High 198.42 / 202.26
52 Wk Low/High 132.75 / 217.16
Avg Volume 171.10K
Exchange NASDAQ
Shares Outstanding 38.06M
Market Cap 7.67B
EPS 2.50
P/E Ratio 81.58
Div & Yield 1.28 (0.64%)

Latest News

Bio-Techne Leverages The RNAscope™ Technology To Advance A Multiomic Approach To Antibody Validation

Bio-Techne Leverages The RNAscope™ Technology To Advance A Multiomic Approach To Antibody Validation

MINNEAPOLIS, Oct. 7, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a family of brands with a unique and leading portfolio of reagents and instruments for life science and clinical research, has been validating a growing number of...

Bio-Techne Attains ISO 9001:2015 Certification For Fetal Bovine Serum Manufacturing Facility

Bio-Techne Attains ISO 9001:2015 Certification For Fetal Bovine Serum Manufacturing Facility

MINNEAPOLIS, Sept. 16, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it has attained ISO 9001:2015 certification at its fetal bovine serum (FBS) and specialty media manufacturing facility in Flowery Branch, Georgia.

Bio-Techne Introduces Maurice Empower® Control Kit For The Maurice™ System

Bio-Techne Introduces Maurice Empower® Control Kit For The Maurice™ System

MINNEAPOLIS, Aug. 20, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the release of the Maurice Empower ® Control Kit for the ProteinSimple™-branded Maurice platform.

Bio-Techne To Present At The Baird 2019 Global Healthcare Conference

Bio-Techne To Present At The Baird 2019 Global Healthcare Conference

MINNEAPOLIS, Aug. 15, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Baird 2019 Global Healthcare Conference on Wednesday, September 4, 2019, at...

Bio-Techne And Cygnus Technologies Announce Partnership For 3G CHO-HCP Assay

Bio-Techne And Cygnus Technologies Announce Partnership For 3G CHO-HCP Assay

MINNEAPOLIS and SOUTHPORT, N.C.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CRAI, GS, MGY, MTLS, NAVI, SEAS Downgrades: AES, CPSI, GIFI, LILA, LILAK, MSCI, MTR, NCLH, OEC, SJM, TECH, UGI Initiations: IMV, LASR, USAC Read on to get TheStreet Quant Ratings' detailed report:

Bio-Techne Declares Dividend

Bio-Techne Declares Dividend

MINNEAPOLIS, Aug. 6, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.

Bio-Techne Releases Fourth Quarter Fiscal 2019 Results

Bio-Techne Releases Fourth Quarter Fiscal 2019 Results

MINNEAPOLIS, Aug. 6, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the fourth quarter ended June 30, 2019.

Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay

Uman Diagnostics And Bio-Techne Announce License And Supply Agreement For Neurofilament Light Assay

MINNEAPOLIS, July 23, 2019 /PRNewswire/ -- Uman Diagnostics, now part of Quanterix, and Bio-Techne announced today a strategic License and Supply Agreement for the antibodies used in the quantification of neurofilament light (Nf-L) on the...

Bio-Techne To Host Conference Call On August 6, 2019, To Announce Fourth Quarter 2019 Financial Results

Bio-Techne To Host Conference Call On August 6, 2019, To Announce Fourth Quarter 2019 Financial Results

MINNEAPOLIS, July 18, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that management will host a conference call on Tuesday, August 6, 2019, at 8:00 a.

Bio-Techne Releases 32x8 Cartridge For The Ella Platform

Bio-Techne Releases 32x8 Cartridge For The Ella Platform

MINNEAPOLIS, July 17, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced the launch of a new 8-Plex cartridge format for the ProteinSimple™-branded Ella™ automated immunoassay platform.

Bio-Techne Announces Commercial Release Of RNAscope® HiPlex Assay: A Multiplex In Situ Hybridization Assay For Tissues

Bio-Techne Announces Commercial Release Of RNAscope® HiPlex Assay: A Multiplex In Situ Hybridization Assay For Tissues

Expanding research tools for Spatial Genomics by combining molecular information with spatial context in one simple assay.

Bio-Techne CEO Chuck Kummeth Wins Entrepreneur Of The Year® 2019 Award In The Heartland

Bio-Techne CEO Chuck Kummeth Wins Entrepreneur Of The Year® 2019 Award In The Heartland

MINNEAPOLIS, July 9, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that its President and CEO, Chuck Kummeth, was recently honored with the EY Entrepreneur Of The Year ® 2019 Award in the Heartland.

Bio-Techne China Recognized With "Decade Of Contribution Award"

Bio-Techne China Recognized With "Decade Of Contribution Award"

MINNEAPOLIS, June 26, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) was recently honored with the "Decade of Contribution Award" at the 2019 (10th) International Conference on Cell Therapy conference.

Bio-Techne Appoints Rupert Vessey To Board Of Directors

Bio-Techne Appoints Rupert Vessey To Board Of Directors

MINNEAPOLIS, June 25, 2019 /PRNewswire/ -- Bio-Techne Corporation today announced the appointment of Dr.

FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx™ Prostate IntelliScore™ (EPI) Test

FDA Grants Breakthrough Device Designation To Bio-Techne's ExoDx™ Prostate IntelliScore™ (EPI) Test

MINNEAPOLIS, June 17, 2019 /PRNewswire/ -- Bio-Techne today announced that the U.

Bio-Techne Receives Approval To Offer The ExoDx™ Prostate Intelliscore™ (EPI) Test In New York State

Bio-Techne Receives Approval To Offer The ExoDx™ Prostate Intelliscore™ (EPI) Test In New York State

The EPI prostate biopsy rule-out test is now available in every state

Bio-Techne To Acquire B-MoGen Biotechnologies Inc.

Bio-Techne To Acquire B-MoGen Biotechnologies Inc.

MINNEAPOLIS, June 4, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of B-MoGen Biotechnologies Inc.

Bio-Techne To Present At The Goldman Sachs 40th Annual Global Healthcare Conference

Bio-Techne To Present At The Goldman Sachs 40th Annual Global Healthcare Conference

MINNEAPOLIS, June 3, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Goldman Sachs 40 th Annual Global Healthcare Conference on Tuesday, June 11 th,...

Bio-Techne's New Exosome-Based Liquid Biopsies Helping To Advance Personalized Care In Lung Cancer Diagnostics

Bio-Techne's New Exosome-Based Liquid Biopsies Helping To Advance Personalized Care In Lung Cancer Diagnostics

MINNEAPOLIS, May 28, 2019 /PRNewswire/ -- Bio-Techne today announced the publication of a recent validation study demonstrating that the proprietary exosome-based liquid biopsy tests from Bio-Techne's Exosome Diagnostics brand may be used to assess the...

Bio-Techne To Present At The Jefferies 2019 Global Healthcare Conference

Bio-Techne To Present At The Jefferies 2019 Global Healthcare Conference

MINNEAPOLIS, May 21, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the Jefferies 2019 Global Healthcare Conference on Wednesday, June 5 th, 2019, at...

Bio-Techne To Present At The UBS Global Healthcare Conference

Bio-Techne To Present At The UBS Global Healthcare Conference

MINNEAPOLIS, May 14, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the UBS Global Healthcare Conference on Wednesday, May 22 nd, 2019, at 9:00 a.

Roche Expands Partnership With Bio-Techne To Offer Drug Discovery Researchers New Chromogenic Detection Options For MRNA ISH Tissue Analysis

Roche Expands Partnership With Bio-Techne To Offer Drug Discovery Researchers New Chromogenic Detection Options For MRNA ISH Tissue Analysis

New Roche detection kits, combined with Bio-Techne's ACD RNAscope® reagent kits, increase singleplex and multiplex testing capabilities on automated platform

Bio-Techne To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference

Bio-Techne To Present At The Bank Of America Merrill Lynch 2019 Health Care Conference

MINNEAPOLIS, May 2, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today announced that Jim Hippel, Chief Financial Officer will present at the Bank of America Merrill Lynch 2019 Health Care Conference on Wednesday, May 15 th, 2019, at 2:20 p.

Bio-Techne Declares Dividend

Bio-Techne Declares Dividend

MINNEAPOLIS, April 30, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) announced that its Board of Directors has decided to pay a dividend of $0.

Bio-Techne Releases Third Quarter Fiscal 2019 Results

Bio-Techne Releases Third Quarter Fiscal 2019 Results

MINNEAPOLIS, April 30, 2019 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) today reported its financial results for the third quarter ended March 31, 2019.

Trade Wars: Winners & Losers for Investors

Trade Wars: Winners & Losers for Investors

Argus Research details 24 stocks likely to be impacted, one way or the other, by trade wars and tariffs.

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

After acquiring Amsterdam-based Patheon, TMO will continue its focus on collecting future companies into its back pocket.

TheStreet Quant Rating: C+ (Hold)